Adma Biologics | ADMA - Beneficio Bruto En Ventas

Precio De Mercado
8.27
Cambio Diario
-0.23 -2.71%
Mensual
-23.00%
Anual
-58.00%
Q2 Expectativa
8.10




Beneficio Bruto En Ventas Cambio Fecha
Adma Biologics USD 88.82M 13.19M 2025-12
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
Minerva Neurosciences -4.27M 26.79M 2024-12
Novavax USD 125.04M 76.09M 2025-12
Omeros USD -33.16M 18.52M 2024-06
Takeda JPY 688.84B 101.71B 2026-03